These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


416 related items for PubMed ID: 21964009

  • 21. In-hospital management and mortality in elderly patients with non-ST-segment elevation acute coronary syndromes treated in centers without on-site invasive facilities.
    Dziewierz A, Siudak Z, Rakowski T, Zdzienicka J, Dykla D, Mielecki W, Dubiel JS, Dudek D.
    Cardiol J; 2008; 15(5):451-7. PubMed ID: 18810721
    [Abstract] [Full Text] [Related]

  • 22. Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge.
    Lee HY, Cooke CE, Robertson TA.
    J Manag Care Pharm; 2008 Apr; 14(3):271-80. PubMed ID: 18439049
    [Abstract] [Full Text] [Related]

  • 23. Utilization of Evidence-Based Secondary Prevention Medications at the Time of Discharge in Patients with Acute Coronary Syndrome (ACS) in Qatar.
    El-Hajj MS, Saad A, Al-Suwaidi J, Al-Marridi WZ, Elkhalifa DH, Mohamed AA, Mahfoud ZR.
    Curr Vasc Pharmacol; 2016 Apr; 14(4):394-403. PubMed ID: 26916397
    [Abstract] [Full Text] [Related]

  • 24. Impact of early coronary artery bypass graft in an unselected acute coronary syndrome patient population.
    Monteiro P, Portuguese Registry on Acute Coronary Syndromes.
    Circulation; 2006 Jul 04; 114(1 Suppl):I467-72. PubMed ID: 16820620
    [Abstract] [Full Text] [Related]

  • 25. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome.
    Yan AT, Yan RT, Tan M, Huynh T, Soghrati K, Brunner LJ, DeYoung P, Fitchett DH, Langer A, Goodman SG, Canadian ACS Registries Investigators.
    Am Heart J; 2007 Dec 04; 154(6):1108-15. PubMed ID: 18035083
    [Abstract] [Full Text] [Related]

  • 26. [Two year follow-up of acute ischemic syndrome without ST elevation].
    Tan HQ, Zhu J, Liang Y, Zhang Y, Liu LS, Chinese Coordinating Center of OASIS Registry.
    Zhonghua Yi Xue Za Zhi; 2005 Jan 19; 85(3):184-8. PubMed ID: 15854465
    [Abstract] [Full Text] [Related]

  • 27. Mapping geographic areas of high and low drug adherence in patients prescribed continuing treatment for acute coronary syndrome after discharge.
    Hoang C, Kolenic G, Kline-Rogers E, Eagle KA, Erickson SR.
    Pharmacotherapy; 2011 Oct 19; 31(10):927-33. PubMed ID: 21950639
    [Abstract] [Full Text] [Related]

  • 28. Secondary prevention for acute coronary syndrome in rural South Australia: are drugs best? What about the rest?
    Wachtel TM, Kucia AM, Greenhill JA.
    Rural Remote Health; 2008 Oct 19; 8(4):967. PubMed ID: 18855517
    [Abstract] [Full Text] [Related]

  • 29. Preventing recurrent events long term after coronary artery bypass graft: suboptimal use of medications in a population study.
    Bradshaw PJ, Jamrozik K, Gilfillan I, Thompson PL.
    Am Heart J; 2004 Jun 19; 147(6):1047-53. PubMed ID: 15199354
    [Abstract] [Full Text] [Related]

  • 30. Optimizing prevention and guideline-concordant care in Montenegro.
    Knežević B, Musić L, Batrićević G, Bošković A, Bulatović N, Nenezić A, Vujović J, Kalezić M.
    Int J Cardiol; 2016 Aug 19; 217 Suppl():S32-6. PubMed ID: 27381861
    [Abstract] [Full Text] [Related]

  • 31. Suboptimal use of evidence-based medical therapy in patients with acute myocardial infarction from the Korea Acute Myocardial Infarction Registry: prescription rate, predictors, and prognostic value.
    Lee JH, Yang DH, Park HS, Cho Y, Jeong MH, Kim YJ, Kim KS, Hur SH, Seong IW, Hong TJ, Cho MC, Kim CJ, Jun JE, Park WH, Chae SC, Korea Acute Myocardial Infarction Registry Investigators.
    Am Heart J; 2010 Jun 19; 159(6):1012-9. PubMed ID: 20569714
    [Abstract] [Full Text] [Related]

  • 32. Use of evidence-based therapy for the secondary prevention of acute coronary syndromes in Malaysian practice.
    Kassab YW, Hassan Y, Aziz NA, Akram H, Ismail O.
    J Eval Clin Pract; 2013 Aug 19; 19(4):658-63. PubMed ID: 22845427
    [Abstract] [Full Text] [Related]

  • 33. Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction.
    Austin PC, Tu JV, Ko DT, Alter DA.
    CMAJ; 2008 Oct 21; 179(9):901-8. PubMed ID: 18936455
    [Abstract] [Full Text] [Related]

  • 34. Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study.
    Blackburn DF, Dobson RT, Blackburn JL, Wilson TW, Stang MR, Semchuk WM.
    Can J Cardiol; 2005 May 01; 21(6):485-8. PubMed ID: 15917876
    [Abstract] [Full Text] [Related]

  • 35. Management of patients admitted with an Acute Coronary Syndrome in New Zealand: results of a comprehensive nationwide audit.
    Ellis C, Gamble G, French J, Devlin G, Matsis P, Elliott J, Mann S, Williams M, White H, New Zealand Acute Coronary Syndromes [NZACS] Audit Group.
    N Z Med J; 2004 Jul 09; 117(1197):U953. PubMed ID: 15326506
    [Abstract] [Full Text] [Related]

  • 36. Clinical presentation and outcomes of acute coronary syndromes in the gulf registry of acute coronary events (Gulf RACE).
    Zubaid M, Rashed WA, Al-Khaja N, Almahmeed W, Al-Lawati J, Sulaiman K, Al-Motarreb A, Amin H, Al-Suwaidi J, Al-Habib K.
    Saudi Med J; 2008 Feb 09; 29(2):251-5. PubMed ID: 18246236
    [Abstract] [Full Text] [Related]

  • 37. Interventions to improve guideline compliance following coronary artery bypass grafting.
    Yam FK, Akers WS, Ferraris VA, Smith K, Ramaiah C, Camp P, Flynn JD.
    Surgery; 2006 Oct 09; 140(4):541-7; discussion 547-52. PubMed ID: 17011901
    [Abstract] [Full Text] [Related]

  • 38. Elderly patients undergoing major vascular surgery: risk factors and medication associated with risk reduction.
    Feringa HH, Bax JJ, Karagiannis SE, Noordzij P, van Domburg R, Klein J, Poldermans D.
    Arch Gerontol Geriatr; 2009 Oct 09; 48(1):116-20. PubMed ID: 18177954
    [Abstract] [Full Text] [Related]

  • 39. Effects of a secondary prevention combination therapy with an aspirin, an ACE inhibitor and a statin on 1-year mortality of patients with acute myocardial infarction treated with a beta-blocker. Support for a polypill approach.
    Zeymer U, Jünger C, Zahn R, Bauer T, Bestehorn K, Senges J, Gitt A.
    Curr Med Res Opin; 2011 Aug 09; 27(8):1563-70. PubMed ID: 21682553
    [Abstract] [Full Text] [Related]

  • 40. Medication in relation to ST-segment elevation myocardial infarction in patients with a first myocardial infarction: Swedish Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA).
    Björck L, Wallentin L, Stenestrand U, Lappas G, Rosengren A.
    Arch Intern Med; 2010 Aug 09; 170(15):1375-81. PubMed ID: 20696964
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 21.